Form 4: Kiniksa Pharmaceuticals Executive Ross Moat Reports Share Transactions
SEC Form 4 Filing
Ross Moat, Chief Commercial Officer of Kiniksa Pharmaceuticals International, plc, reports the acquisition and disposal of Class A Ordinary Shares and Restricted Share Units on April 7, 2025.
Summary
- On April 7, 2025, Ross Moat, the Chief Commercial Officer of Kiniksa Pharmaceuticals International, plc, engaged in transactions involving the company's Class A Ordinary Shares and Restricted Share Units (RSUs).
- Moat acquired 2,477 Class A Ordinary Shares through the vesting of RSUs.
- He also disposed of 727 Class A Ordinary Shares at a price of $20.28 per share.
- Following these transactions, Moat directly owns 27,674 Class A Ordinary Shares and 2,477 Restricted Share Units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting insider transactions, which is neutral in sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key executives and their potential impact on the company's stock.
Stakeholder Impact
- Shareholders can use this information to understand the actions of company insiders.
- The transactions may have a minor impact on the stock price due to the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 04/07/2022 | Date of grant for the Restricted Share Units, which vest over a four-year period. |
| 04/07/2025 | Date of the reported transactions: acquisition of shares through RSU vesting and disposal of shares. |
| 04/09/2025 | Date of signature on the Form 4 filing. |
Keywords
Kiniksa Pharmaceuticals, Ross Moat, Class A Ordinary Shares, Restricted Share Units, Form 4, SEC Filing, Insider Trading, Beneficial Ownership, Transaction Report
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.